Open AccessIs there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?
Author(s) -
Giandomenico Roviello,
Silvia Paola Corona,
Raffaele Conca,
Roberto Petrioli,
Pietro Rosellini,
Alberto Bonetta,
Michele Aieta
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000016249
Subject(s) - medicine , vinorelbine , enzalutamide , prostate cancer , cabazitaxel , tolerability , docetaxel , abiraterone acetate , oncology , chemotherapy , surgery , urology , cancer , androgen deprivation therapy , adverse effect , cisplatin , androgen receptor